|
Market Closed -
Nasdaq Stockholm
15:30:00 30/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 23.20 SEK | -.--% |
|
+10.48% | -27.39% |
| 10-28 | C-Rad Bags SEK8 Million Order From US Medical Center | MT |
| 10-28 | C-Rad receives US order worth approximately SEK 8m | FW |
Company Valuation: C-Rad AB
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 1,880 | 1,287 | 1,421 | 1,007 | 1,073 | 783.4 | - | - |
| Change | - | -31.57% | 10.47% | -29.12% | 6.5% | -26.98% | - | - |
| Enterprise Value (EV) 1 | 1,758 | 1,165 | 1,292 | 856.5 | 901.6 | 625.5 | 582.1 | 536.2 |
| Change | - | -33.74% | 10.92% | -33.7% | 5.28% | -30.62% | -6.95% | -7.88% |
| P/E | 75.3x | 173x | 31x | 18x | 103x | 13.8x | 11.8x | 9.41x |
| PBR | 8.13x | 5.31x | 5.06x | 3.12x | 3.11x | 2.04x | 1.81x | 1.59x |
| PEG | - | -2.5x | 0x | 0.8x | -1.3x | 0x | 0.7x | 0.4x |
| Capitalization / Revenue | 7.2x | 4.27x | 3.35x | 2.15x | 2.43x | 1.89x | 1.72x | 1.59x |
| EV / Revenue | 6.73x | 3.87x | 3.04x | 1.83x | 2.04x | 1.51x | 1.28x | 1.09x |
| EV / EBITDA | 38.5x | 32.2x | 19.5x | 10.7x | 16.3x | 8x | 5.9x | 4.57x |
| EV / EBIT | 48.8x | 44.6x | 22.5x | 12.2x | 20x | 9.84x | 7.01x | 5.14x |
| EV / FCF | 143x | -760x | 78.8x | 36.6x | 17.9x | 14.1x | 9.53x | 7.86x |
| FCF Yield | 0.7% | -0.13% | 1.27% | 2.73% | 5.58% | 7.11% | 10.5% | 12.7% |
| Dividend per Share 2 | - | - | - | - | 0.1 | 0.45 | 0.55 | 0.7 |
| Rate of return | - | - | - | - | 0.31% | 1.94% | 2.37% | 3.02% |
| EPS 2 | 0.74 | 0.22 | 1.36 | 1.67 | 0.31 | 1.686 | 1.96 | 2.465 |
| Distribution rate | - | - | - | - | 32.3% | 26.7% | 28.1% | 28.4% |
| Net sales 1 | 261.2 | 301.3 | 424.6 | 469 | 441.9 | 413.7 | 454.6 | 493.9 |
| EBITDA 1 | 45.7 | 36.2 | 66.4 | 79.9 | 55.4 | 78.18 | 98.64 | 117.3 |
| EBIT 1 | 36 | 26.1 | 57.5 | 70 | 45.1 | 63.58 | 82.99 | 104.2 |
| Net income 1 | 25.1 | 7.5 | 46.1 | 56.5 | 10.5 | 56.83 | 66.07 | 83.08 |
| Net Debt 1 | -122.4 | -121.9 | -129.4 | -150.9 | -171.2 | -157.9 | -201.3 | -247.2 |
| Reference price 2 | 55.70 | 38.10 | 42.20 | 30.00 | 31.95 | 23.20 | 23.20 | 23.20 |
| Nbr of stocks (in thousands) | 33,752 | 33,767 | 33,678 | 33,578 | 33,578 | 33,767 | - | - |
| Announcement Date | 1/27/22 A | 1/26/23 A | 2/8/24 A | 2/7/25 A | 2/12/26 A | - | - | - |
1SEK in Million2SEK
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 13.76x | 1.51x | 8x | 1.94% | 79.74M | |
| 35.69x | 6.08x | 23.25x | 0.27% | 258B | |
| 36.92x | 7x | 21.93x | 0.62% | 163B | |
| 49.76x | 12.05x | 25.86x | -.--% | 150B | |
| 17x | 3.45x | 11.22x | -.--% | 60.84B | |
| 21x | 2.51x | 12.66x | 2.4% | 53.31B | |
| 36.47x | 7.31x | 23.11x | -.--% | 53.03B | |
| 47.92x | 11.82x | 26.05x | -.--% | 50.67B | |
| 34.07x | 6.75x | 22.92x | 0.59% | 49.3B | |
| 81x | 7.7x | 23.37x | -.--% | 45.46B | |
| Average | 37.36x | 6.62x | 19.84x | 0.58% | 88.41B | |
| Weighted average by Cap. | 39.11x | 7.39x | 22.12x | 0.37% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- CRAD B Stock
- Valuation C-Rad AB
Select your edition
All financial news and data tailored to specific country editions
